# Sitemap # Sitemap - [Home](/ "Neuroscience & Biomarker Solutions for CNS Clinical Trials") - [Company](/company/ "About IXICO | Neuroimaging & Biomarker Experts Since 2004") - [Mission](/company/#mission "Mission") - [About IXICO](/company/#about-ixico "About IXICO") - IXI™ Platform - [The Power of Neuroimaging](/company/#the-power-of-neuroimaging "The Power of Neuroimaging") - [Customers ](/company/customers/ "Our Customers | Pharma & Biotech Partners | IXICO") - [Partnerships](/company/partnerships/ "Partnerships | Neuroimaging, Technology and Research Collaborations | IXICO") - [Leadership Team](/company/#advisors "Leadership Team") - [Advisors](/company/#advisors "Advisors") - [Careers](/company/careers/ "Careers") - [Business Development Director](/company/careers/business-development-director/ "Business Development Director") - [Director, Neuroscience Medical Affairs ](/company/careers/director-neuroscience-medical-affairs/ "Director of Neuroscience Medical Affairs") - [Associate Image Analyst](/company/careers/associate-image-analyst/ "Associate Image Analyst") - [IXI Platform Delivery Lead](/company/careers/ixi-platform-delivery-lead/ "IXI Platform Delivery Lead") - [Associate Director/Director Corporate Development & Partnership](/company/careers/associate-directordirector-corporate-development-and-partnership/ "Associate Director/Director Corporate Development & Partnership") - [Recruitment privacy notice](/company/careers/recruitment-privacy-notice/ "Recruitment Privacy Notice | IXICO Careers") - [IXI™ Platform](/platform/ "IXI Platform | AI Imaging - AI-Powered Neuroimaging Technology") - [AI-Driven Insights](/platform/#insights-derived-from-imaging-biomarker-data "AI-Driven Insights") - [Platform Features](/platform/#platform-highlights "Platform Features") - [Platform Evolution](/platform/#platform-evolution "Platform Evolution") - [Services ](/services/ "Neuroimaging & Biomarker Services for CNS Clinical Trials") - [Imaging Biomarker ](/services/imaging-biomarkers/ "Imaging Biomarker Analysis for CNS Clinical Trials | IXICO") - [Radiological reads ](/services/imaging-biomarkers/radiological-reads/ "Radiological Reads for CNS Clinical Trials | IXICO") - [Volumetric MRI](/services/imaging-biomarkers/volumetric-mri/ "Volumetric MRI Biomarker Analysis for CNS Trials | IXICO") - [PET & SPECT ](/services/imaging-biomarkers/pet-and-spect/ "PET & SPECT Imaging Services for CNS Clinical Trials | IXICO") - [Advanced MRI ](/services/imaging-biomarkers/advanced-mri/ "Advanced MRI Biomarker Analytics for CNS Trials | IXICO") - [Trial Management ](/services/trial-management/ "Clinical Trial Imaging Management | IXICO") - [Data Analytics](/services/data-analytics/ "Neuroimaging Data Analytics & Biomarker Data Analysis | IXICO") - [Post-Marketing Surveillance](/services/post-marketing/ "Post-Marketing Surveillance | Neurological Imaging") - [Consultancy](/services/consultancy/ "Consultancy") - [Therapeutic Expertise](/therapeutic-areas/ "Therapeutic Areas | CNS & Neurological Disease Imaging | IXICO") - [Alzheimer's Disease (AD)](/therapeutic-areas/alzheimers-disease/ "Alzheimer's Disease Biomarkers | IXICO") - [Huntington's Disease (HD)](/therapeutic-areas/huntingtons-disease/ "Huntington's Disease Neuroimaging & Biomarker Analytics | IXICO") - [Parkinson's Disease (PD)](/therapeutic-areas/parkinsons-disease/ "Parkinson's Disease Biomarkers | IXICO") - [Multiple Sclerosis (MS)](/therapeutic-areas/multiple-sclerosis/ "Multiple Sclerosis Neuroimaging & Biomarker Analytics | IXICO") - [Other Rare Neurological Diseases](/therapeutic-areas/therapeutic-areas-2/ "Rare Neurological Disease Neuroimaging Services | IXICO") - [Recent Scientific Publications](/therapeutic-areas/recent-scientific-publications/ "Recent Scientific Publications | IXICO Neuroimaging Research") - [News & Resources](/news-and-resources/ "News & Resources ") - [News](/news-and-resources/news/ "News") - [Global clinical trial contract wins in Alzheimer’s Disease and Friedreich’s Ataxia ](/news-and-resources/news/global-clinical-trial-contract-wins-in-alzheimers-disease-and-friedreichs-ataxia/ "Global clinical trial contract wins in Alzheimer’s Disease and Friedreich’s Ataxia ") - [IXICO and Global Alzheimer’s Platform Foundation Announces Strategic Collaboration](/news-and-resources/news/ixico-and-global-alzheimers-platform-foundation-announces-strategic-collaboration-and-partnership-for-the-transformative-bio-hermes-002-study/ "IXICO and Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership for the Transformative Bio-Hermes-002 Study") - [Revenues anticipated to be ahead of expectations for the year ending 30 September 2025](/news-and-resources/news/revenues-anticipated-to-be-ahead-of-expectations-for-the-year-ending-30-september-2025/ "Revenues anticipated to be ahead of expectations for the year ending 30 September 2025") - [IXICO assists first FDA clearance of new Alzheimer’s Disease blood based diagnostic biomarker](/news-and-resources/news/ixico-assists-first-fda-clearance-of-new-alzheimers-disease-blood-based-diagnostic-biomarker/ "IXICO assists first FDA clearance of new Alzheimer’s Disease blood based diagnostic biomarker") - [Interim results for six months ending 31 March 2025 ](/news-and-resources/news/interim-results-for-six-months-ending-31-march-2025/ "Interim results for six months ending 31 March 2025 ") - [Half-year Trading update - FY2025](/news-and-resources/news/half-year-trading-update-fy2025/ "Half-year Trading update - FY2025") - [Contract Wins in Alzheimer’s and Huntington’s Disease](/news-and-resources/news/contract-wins-in-alzheimers-and-huntingtons-disease/ "Contract Wins in Alzheimer’s and Huntington’s Disease") - [Huntington’s Disease consortium further validates IXICO’s AI imaging platform](/news-and-resources/news/huntingtons-disease-consortium-further-validates-ixicos-ai-imaging-platform/ "Huntington’s Disease consortium further validates IXICO’s AI imaging platform") - [Commercial agreement with PETNET Solutions Inc, a Siemens Healthineers Company](/news-and-resources/news/commercial-agreement-with-petnet-solutions-inc-a-siemens-healthineers-company/ "Commercial agreement with PETNET Solutions Inc, a Siemens Healthineers Company") - [US Client Clinical Trial Contract Win](/news-and-resources/news/us-client-clinical-trial-contract-win-dec-2024/ "US Client Clinical Trial Contract Win") - [Appointment of CEO - Bram Goorden](/news-and-resources/news/appointment-of-ceo-bram-goorden/ "Appointment of CEO - Bram Goorden") - [ IXICO to support on Global Alzheimer's Platform Foundation's Bio-Hermes 2 trial](/news-and-resources/news/global-alzheimers-platform-foundation-bio-hermes-2-trial/ " IXICO to support on Global Alzheimer's Platform Foundation's Bio-Hermes 2 trial") - [Life Molecular Imaging Collaboration Agreement](/news-and-resources/news/life-molecular-imaging-collaboration-agreement/ "Life Molecular Imaging Collaboration Agreement") - [Imeka Collaboration Agreement](/news-and-resources/news/imeka-collaboration-agreement/ "Imeka Collaboration Agreement") - [The impact of diversity on Alzheimer's disease clinical trial design](/news-and-resources/news/the-impact-of-diversity-on-alzheimers-disease-clinical-trial-design/ "The impact of diversity on Alzheimer's disease clinical trial design") - [Huntington’s Disease Image Harmonization Consortium](/news-and-resources/news/huntingtons-disease-image-harmonization-consortium-secures-new-member-and-funding-to-complete-large-scale-analysis-of-brain-changes-using-ixiq-ai/ "Huntington’s Disease Image Harmonization Consortium secures new member and funding to complete large-scale analysis of brain changes using IXIQ.Ai") - [Call to Action – New consortium will use AI](/news-and-resources/news/call-to-action-new-consortium-will-use-artificial-intelligence-technology-to-conduct-large-scale-analysis-of-brain-changes-in-huntingtons-disease/ "Call to Action – New consortium will use artificial intelligence technology to conduct large-scale analysis of brain changes in Huntington’s disease") - [Engagement in New Consortium](/news-and-resources/news/engagement-in-new-consortium-in-huntingtons-disease/ "Engagement in New Consortium in Huntington’s disease") - [IXICO hails the introduction of IXIQ.Ai, its new brain imaging technology ](/news-and-resources/news/first-contract-award-from-new-imaging-master-vendor-agreement-with-top-5-global-cro/ "IXICO hails the introduction of IXIQ.Ai, its new brain imaging technology ") - [IXICO primed to solve the challenge of increased clinical trial complexity](/news-and-resources/news/going-for-growth-ixico-primed-to-solve-the-challenge-of-increased-clinical-trial-complexity-through-ai-advances/ "Going for growth: IXICO primed to solve the challenge of increased clinical trial complexity through AI advances") - [Giulio Cerroni in S&P Global Market Intelligence interview](/news-and-resources/news/as-clinical-trials-become-more-complex-were-seeing-the-use-of-medical-imaging-increasing-says-giulio-cerroni-in-s-and-p-global-market-intelligence-interviewnew-blog-post/ ""As clinical trials become more complex, we're seeing the [use of] medical imaging increasing" says Giulio Cerroni in S&P Global Market Intelligence interviewNew Blog Post") - [AMYPAD's interview with Katherine Gray](/news-and-resources/news/amypads-interview-with-katherine-gray-ixicos-associate-director-of-technologynew-blog-post/ "AMYPAD's interview with Katherine Gray, IXICO's associate director of technology") - [BGF investment fund's Paul Stevens](/news-and-resources/news/bgf-investment-funds-paul-stevens-ixico-has-market-leading-position-and-impressive-commercial-traction/ "BGF investment fund's Paul Stevens: IXICO has “market leading position" & “impressive commercial traction”") - [Investors chronicle: 'IXICO upgrades guidance again'](/news-and-resources/news/investors-chronicle-ixico-upgrades-guidance-again/ "Investors chronicle: 'IXICO upgrades guidance again'") - [Investors chronicle: 'Profit from artificial intelligence in neuroscience'](/news-and-resources/news/investors-chronicle-profit-from-artificial-intelligence-in-neuroscience/ "Investors chronicle: 'Profit from artificial intelligence in neuroscience'") - [IXICO wins "CRO Provider of the Year 2025" at the Precision Medicine Awards](/news-and-resources/news/ixico-wins-cro-provider-of-the-year-2025-at-the-precision-medicine-awards/ "IXICO wins "CRO Provider of the Year 2025" at the Precision Medicine Awards") - [New blood based biomarker contract win and contract extension worth a total of £1.2 million](/news-and-resources/news/new-blood-based-biomarker-contract-win-and-contract-extension-worth-a-total-of-1-2-million/ "New blood based biomarker contract win and contract extension worth a total of £1.2 million") - [Trading update for the year ended 30 September 2025](/news-and-resources/news/trading-update-for-the-year-ended-30-september-2025/ "Trading update for the year ended 30 September 2025") - [Capital Markets Day 2025](/news-and-resources/news/capital-markets-day-2025/ "Capital Markets Day 2025") - [Global Phase 3 Clinical Trial Contract Win](/news-and-resources/news/global-phase-3-clinical-trial-contract-win/ "Global Phase 3 Clinical Trial Contract Win") - [IXICO strengthens Scientific Advisory Board with two prominent global Alzheimer’s Disease experts](/news-and-resources/news/ixico-strengthens-scientific-advisory-board-with-two-prominent-global-alzheimers-disease-and-vascular-experts/ "IXICO strengthens Scientific Advisory Board with two prominent global Alzheimer’s Disease and vascular experts") - [Financial Results for year ended 30 September 2025 and Notice of AGM](/news-and-resources/news/financial-results-for-year-ended-30-september-2025-and-notice-of-agm/ "Financial Results for year ended 30 September 2025 and Notice of AGM") - [IXICO appoints Chief Commercial Officer to accelerate business development activity ](/news-and-resources/news/ixico-appoints-chief-commercial-officer-to-accelerate-business-development-activity-and-broaden-us-footprint/ "IXICO appoints Chief Commercial Officer to accelerate business development activity and broaden US footprint ") - [c.£1.5 million contract extension on global Phase 2 clinical trial ](/news-and-resources/news/c-1-5-million-contract-extension-on-global-phase-2-clinical-trial/ "c.£1.5 million contract extension on global Phase 2 clinical trial ") - [IXICO further validates the automation capabilities of its IXI™ neuroimaging technology platform](/news-and-resources/news/ixico-further-validates-the-automation-capabilities-of-its-ixi-neuroimaging-technology-platform/ "IXICO further validates the automation capabilities of its IXI™ neuroimaging technology platform") - [IXICO and Medidata collaborate to create an advanced neuroimaging clinical trials platform ](/news-and-resources/news/ixico-and-medidata-collaborate-to-create-an-advanced-neuroimaging-clinical-trials-platform/ "IXICO and Medidata collaborate to create an advanced neuroimaging clinical trials platform ") - [IXICO RELEASES LATEST VERSION OF AI-DRIVEN NEUROIMAGING TECHNOLOGY PLATFORM](/news-and-resources/news/ixico-releases-latest-version-of-ai-driven-neuroimaging-technology-platform/ "IXICO RELEASES LATEST VERSION OF AI-DRIVEN NEUROIMAGING TECHNOLOGY PLATFORM") - [Interim results for six months ending 31 March 2026. Continued strong revenue and order book growth.](/news-and-resources/news/ixico-plc/ "Interim results for six months ending 31 March 2026. Continued strong revenue and order book growth.") - [IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates](/news-and-resources/news/ixico-reports-strong-h1-revenue-growth-as-alzheimers-trial-demand-accelerates/ "IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates") - [IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER’S AND PARKINSON’S DISEASE](/news-and-resources/news/ixico-expands-research-collaborations-in-alzheimers-and-parkinsons-disease/ "IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER’S AND PARKINSON’S DISEASE") - [IXICO to present advancements in neuroimaging for Parkinson’s disease](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/ "IXICO to present advancements in neuroimaging for Parkinson’s disease at European radiology conference ") - [IXICO announces 28% expected revenue growth for FY26](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/ "IXICO announces 28% expected revenue growth for FY26") - [IXICO announces two contracts in Alzheimer's disease worth £1.5 million](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/ "IXICO announces two contracts in Alzheimer's disease worth £1.5 million") - [Novel methods to reduce unwanted variability in Huntington’s disease biomarker data ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/ "IXICO presents research on novel methods to reduce unwanted variability in Huntington’s disease biomarker data ") - [IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/ "IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease") - [Scientific Publications](/news-and-resources/publications/ "Scientific Publications") - [Neuroimaging Biomarkers for Friedreich's Ataxia: A Cross-Sectional Analysis of the TRACK-FA Study](/news-and-resources/publications/neuroimaging-biomarkers-for-friedreich-ataxia-a-cross-sectional-analysis-of-the-track-fa-study/ "Neuroimaging Biomarkers for Friedreich's Ataxia: A Cross-Sectional Analysis of the TRACK-FA Study") - [Comparison of two natural history studies as part of the HD-IH consortium](/news-and-resources/publications/comparison-of-two-natural-history-studies-as-part-of-the-hd-ih-consortium-a-use-case-for-historical-external-control-group-matching-in-clinical-trials/ "Comparison of two natural history studies as part of the HD-IH consortium: a use case for historical external control group matching in clinical trials") - [Fully automatic detection and quantification of new white matter lesions using deep learning](/news-and-resources/publications/fully-automatic-detection-and-quantification-of-new-white-matter-lesions-using-deep-learning/ "Fully automatic detection and quantification of new white matter lesions using deep learning") - [Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease](/news-and-resources/publications/neuroimaging-to-facilitate-clinical-trials-in-huntingtons-disease-current-opinion-from-the-ehdn-imaging-working-group-ios-press/ "Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press") - [Volumetric change across the different Stages of the Huntington’s disease](/news-and-resources/publications/comparison-of-local-amyloid-pet-uptake-patterns-between-black-and-white-participants-in-the-gap-bio-hermes-study/ "Volumetric change across the different Stages of the Huntington’s disease Integrated Staging System (HD-ISS) defined at baseline") - [Erosion of The Supratentorial White Matter Reference](/news-and-resources/publications/erosion-of-the-supratentorial-white-matter-reference-for-increased-power-in-longitudinal-amyloid-pet/ "Erosion of The Supratentorial White Matter Reference for Increased Power in Longitudinal Amyloid PET ") - [Association between regional volume change and clinical change](/news-and-resources/publications/association-between-regional-volume-change-and-clinical-change-in-huntingtons-disease-hd-iss-stage-2-and-stage-3-participants/ "Association between regional volume change and clinical change in Huntington’s disease HD-ISS Stage 2 and Stage 3 participants") - [A Deep Learning Framework For Clinical Trial Enrichment in Alzheimer’s Disease](/news-and-resources/publications/a-deep-learning-framework-for-clinical-trial-enrichment-in-alzheimers-disease/ "A Deep Learning Framework For Clinical Trial Enrichment in Alzheimer’s Disease") - [Comparison of amyloid positivity and global cortical SUVR](/news-and-resources/publications/comparison-of-amyloid-positivity-and-global-cortical-suvr-between-black-and-white-non-hispanic-participants-in-the-gap-bio-hermes-study/ "Comparison of amyloid positivity and global cortical SUVR between black and white non-Hispanic participants in the GAP Bio-Hermes study") - [A convolutional neural network-based framework ](/news-and-resources/publications/a-convolutional-neural-network-based-framework-for-imaging-biomarkers-in-ms-white-matter-hyperintensity-and-brain-region-volumes-ectrims-2023/ "A convolutional neural network-based framework for imaging biomarkers in MS - white matter hyperintensity & brain region volumes ") - [Automated VMAT2 \[18F\] AV-133 PET analysis in Parkinson's disease](/news-and-resources/publications/automated-vmat2-18f-av-133-pet-analysis-in-parkinsons-disease/ "Automated VMAT2 [18F] AV-133 PET analysis in Parkinson's disease") - [Fully automatic deep-learning based segmentation of hippocampal subfields](/news-and-resources/publications/fully-automatic-deep-learning-based-segmentation-of-hippocampal-subfields-from-standard-resolution-t1w-mri-in-alzheimers-disease/ "Fully automatic deep-learning based segmentation of hippocampal subfields from standard resolution T1W MRI in Alzheimer’s disease") - [MR Imaging in Ataxias Consensus Recommendation](/news-and-resources/publications/mr-imaging-in-ataxias-consensus-recommendations-by-the-ataxia-global-initiative-working-group-on-mri-biomarkers/ "MR Imaging in Ataxias Consensus Recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers") - [Validation of IXIQ.Ai+gBSI](/news-and-resources/publications/validation-of-ixiq-ai-gbsi-an-automated-framework-for-caudate-atrophy-measurement-in-huntingtons-disease/ "Validation of IXIQ.Ai+gBSI : an automated framework for caudate atrophy measurement in Huntington’s disease") - [Validation of a Jacobian AI-based method](/news-and-resources/publications/validation-of-a-jacobian-ai-based-method-to-measure-cerebellar-volume-changes-in-multiple-system-atrophy/ "Validation of a Jacobian AI-based method to measure cerebellar volume changes in multiple system atrophy") - [Deep-learning methods for enrichment of Alzheimer’s Disease clinical trials using MRI and PET](/news-and-resources/publications/deep-learning-methods-for-enrichment-of-alzheimers-disease-clinical-trials-using-mri-and-pet/ "Deep-learning methods for enrichment of Alzheimer’s Disease clinical trials using MRI and PET") - [Amyloid PET centiloid: impact of calibration and processing steps](/news-and-resources/publications/amyloid-pet-centiloid-impact-of-calibration-and-processing-steps/ "Amyloid PET centiloid: impact of calibration and processing steps") - [Application of fully automatic Hippocampal sub-field segmentation volumes](/news-and-resources/publications/application-of-fully-automatic-hippocampal-sub-field-segmentation-volumes-to-standard-resolution-t1-mr-imaging-in-alzheimers-disease/ "Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease") - [MDS 2022 Poster](/news-and-resources/publications/mds-2022-poster-an-automated-ai-based-framework-for-putamen-volume-measurement-in-multiple-system-atrophy/ "MDS 2022 Poster – An automated AI-based framework for putamen volume measurement in Multiple System Atrophy") - [EHDN Imaging Working Group Presentation on new HD-IH Consortium](/news-and-resources/publications/ehdn-imaging-working-group-presentation-on-new-hd-ih-consortium/ "EHDN Imaging Working Group Presentation on new HD-IH Consortium") - [AD/PD 2021 Poster - Automatic segmentation using deep learning for the hippocampus](/news-and-resources/publications/adpd-2021-poster-automatic-segmentation-using-deep-learning-for-the-hippocampus/ "AD/PD 2021 Poster - Automatic segmentation using deep learning for the hippocampus") - [AD/PD 2021 Poster](/news-and-resources/publications/adpd-2021-poster-an-adaptive-step-detection-algorithm-for-waist-worn-wearable-devices-a-feasibility-study-in-older-adults/ "AD/PD 2021 Poster - An adaptive step detection algorithm for waist-worn wearable devices: A feasibility study in older adults") - [AD/PD 2021 Poster - Added value of wearable sensors for fall risk assessment in an older adult group](/news-and-resources/publications/adpd-2021-poster/ "AD/PD 2021 Poster - Added value of wearable sensors for fall risk assessment in an older adult group") - [IEEE International Conference on Healthcare Informatics (ICHI) 2020 Poster](/news-and-resources/publications/ieee-international-conference-on-healthcare-informatics-ichi-2020-poster/ "IEEE International Conference on Healthcare Informatics (ICHI) 2020 Poster") - [Huntington Study Group (HSG) 2020 Poster](/news-and-resources/publications/huntington-study-group-hsg-2020-poster/ "Huntington Study Group (HSG) 2020 Poster") - [Huntington Study Group (HSG) 2020 Poster](/news-and-resources/publications/huntington-study-group-hsg-2020-poster-2/ "Huntington Study Group (HSG) 2020 Poster") - [Alzheimer's Association International Conference (AAIC) Poster 2020](/news-and-resources/publications/alzheimers-association-international-conference-aaic-poster-2020/ "Alzheimer's Association International Conference (AAIC) Poster 2020") - [Alzheimer's Association International Conference (AAIC) Poster 2020 ](/news-and-resources/publications/alzheimers-association-international-conference-aaic-poster-2/ "Alzheimer's Association International Conference (AAIC) Poster 2020 ") - [Medical Image Understanding and Analysis (MIUA) Publication 2020](/news-and-resources/publications/medical-image-understanding-and-analysis-miua-publication-2020/ "Medical Image Understanding and Analysis (MIUA) Publication 2020") - [Schizophrenia International Research Society (SIRS) 2020 Poster](/news-and-resources/publications/sirs-2020-congress/ "Schizophrenia International Research Society (SIRS) 2020 Poster") - [Quantitative amyloid PET in Alzheimer’s disease: the AMYPAD prognostic and natural history study](/news-and-resources/publications/amyloid-pet-alzheimers-disease-amypad/ "Quantitative amyloid PET in Alzheimer’s disease: the AMYPAD prognostic and natural history study") - [Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Poster 2020](/news-and-resources/publications/adpd-poster-2020/ "Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Poster 2020") - [Advances in Alzheimer’s and Parkinson’s Therapies (AAT-ADPD) Poster 2020](/news-and-resources/publications/advances-in-alzheimers-and-parkinsons-therapies-aat-adpd-poster/ "Advances in Alzheimer’s and Parkinson’s Therapies (AAT-ADPD) Poster 2020") - [CHDI Poster 2020](/news-and-resources/publications/cdhi/ "CHDI Poster 2020") - [Human Amyloid Imaging (HAI) Poster 2020](/news-and-resources/publications/the-impact-of-automatic-tau-pet-processing-on-uptake-variability-and-power-analysis-in-ad/ "Human Amyloid Imaging (HAI) Poster 2020") - [Human Amyloid Imaging (HAI) Poster 2020](/news-and-resources/publications/human-amyloid-imaging-conference/ "Human Amyloid Imaging (HAI) Poster 2020") - [Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019](/news-and-resources/publications/clinical-trials-on-alzheimers-disease-ctad-2019-poster-2/ "Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019") - [Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019](/news-and-resources/publications/clinical-trials-on-alzheimers-disease-ctad-2017-poster/ "Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019") - [Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019](/news-and-resources/publications/clinical-trials-on-alzheimers-disease-ctad-2017-poster-2/ "Clinical Trials on Alzheimer’s Disease (CTAD) Poster 2019") - [Company Annual Report 2019](/news-and-resources/publications/company/ "Company Annual Report 2019") - [Huntington Study Group (HSG) Annual Meeting Poster 2019](/news-and-resources/publications/hsg-poster-nov-2019/ "Huntington Study Group (HSG) Annual Meeting Poster 2019") - [Spinocerebellar Ataxias (SCA) Global Conference 2019 Poster](/news-and-resources/publications/sca-2019/ "Spinocerebellar Ataxias (SCA) Global Conference 2019 Poster") - [Clinical Trials on Alzheimer’s Disease (CTAD) 2017 Poster](/news-and-resources/publications/ctad-2017-poster/ "Clinical Trials on Alzheimer’s Disease (CTAD) 2017 Poster") - [AI-Driven Recruitment for AD Clinical Trials A Pilot Analysis on the A4 Study Dataset](/news-and-resources/publications/ai-driven-recruitment-for-alzheimers-disease-clinical-trials-a-pilot-analysis-on-the-a4-study-dataset/ "AI-Driven Recruitment for Alzheimer’s Disease Clinical Trials: A Pilot Analysis on the A4 Study Dataset") - [Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding](/news-and-resources/publications/agreement-between-amyloid-status-prediction-from-visual-read-suvr-thresholding-and-ai-based-interpretation-of-amyloid-pet/ "Agreement Between Amyloid Status Prediction from Visual Read, SUVR Thresholding, and AI-Based Interpretation of Amyloid PET") - [Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease](/news-and-resources/publications/biomarkers-in-patients-with-clinical-signs-of-mild-cognitive-impairment-or-mild-alzheimers-disease-but-without-amyloid-deposits-on-positron-emission-tomography/ "Biomarkers in patients with clinical signs of mild cognitive impairment or mild Alzheimer's disease but without amyloid deposits on positron emission tomography") - [Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology](/news-and-resources/publications/interchangeability-of-blood-based-biomarkers-and-pet-to-identify-alzheimers-disease-pathology/ "Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology") - [Further validation of IXI technology platform automation capabilities](/news-and-resources/publications/further-validation-of-ixi-technology-platform-automation-capabilities/ "Further validation of IXI technology platform automation capabilities") - [Improving Neuromelanin-sensitive MRI measurement ](/news-and-resources/publications/improving-neuromelanin-sensitive-mri-measurement/ "Improving Neuromelanin-sensitive MRI measurement ") - [Contrast ratio assessment of the substantia nigra in neuromelanin-sensitive MRI](/news-and-resources/publications/contrast-ratio-assessment-of-the-substantia-nigra-in-neuromelanin-sensitive-mri/ "Neuromelanin-Sensitive MRI of the Substantia Nigra: Comparing TSE and MT-GRE Contrast") - [Impact of Scanner Harmonisation on Longitudinal Brain Volume Measures in Huntington’s Disease](/news-and-resources/publications/evaluating-the-impact-of-scanner-harmonisation-in-huntingtons-disease/ "Evaluating the Impact of Scanner Harmonisation with ComBat on Longitudinal Brain Volume Measures in Huntington’s Disease") - [Webinars](/news-and-resources/webinars/ "Webinars") - [Parkinson's Disease: Unveiling the Promise of Neuromelanin Sensitive Imaging](/news-and-resources/webinars/parkinsons-disease-unveiling-the-promise-of-neuromelanin-sensitive-imaging/ "Parkinson's Disease: Unveiling the Promise of Neuromelanin Sensitive Imaging") - [Neurological Disorders - Harmonisation of Imaging in Clinical Trials](/news-and-resources/webinars/neurological-disorders-harmonisation-of-imaging-in-clinical-trials/ "Neurological Disorders - Harmonisation of Imaging in Clinical Trials") - [Advancing Alzheimer's Research](/news-and-resources/webinars/advancing-alzheimers-research-enhancing-clinical-trial-diversity-and-relevant-imaging-considerations/ "Advancing Alzheimer's Research: enhancing clinical trial diversity and relevant imaging considerations") - [Multiple Sclerosis – Advancing treatment through imaging biomarkers](/news-and-resources/webinars/multiple-sclerosis-advancing-treatment-through-imaging-biomarkers/ "Multiple Sclerosis – Advancing treatment through imaging biomarkers") - [Parkinson's Disease - The road ahead for imaging biomarkers](/news-and-resources/webinars/parkinsons-disease-the-road-ahead-for-imaging-biomarkers/ "Parkinson's Disease - The road ahead for imaging biomarkers") - [Huntington's Disease: The present and future of imaging biomarkers ](/news-and-resources/webinars/huntingtons-disease-the-present-and-future-of-imaging-biomarkers/ "Huntington's Disease: The present and future of imaging biomarkers ") - [Gene therapy for the CNS: The roles of neuroimaging](/news-and-resources/webinars/gene-therapy-for-the-cns-the-roles-of-neuroimaging/ "Gene therapy for the CNS: The roles of neuroimaging") - [Alzheimer’s disease: emerging neuroimaging techniques in clinical trials](/news-and-resources/webinars/alzheimers-disease-emerging-neuroimaging-techniques-in-clinical-trials/ "Alzheimer’s disease: emerging neuroimaging techniques in clinical trials") - [Getting neuroimaging right — How to succeed in neurodegenerative clinical trials](/news-and-resources/webinars/getting-neuroimaging-right-how-to-succeed-in-neurodegenerative-clinical-trials/ "Getting neuroimaging right — How to succeed in neurodegenerative clinical trials") - [Clinical and Imaging Biomarkers in Parkinsonian Syndromes](/news-and-resources/webinars/clinical-and-imaging-biomarkers-in-parkinsonian-syndromes/ "Clinical and Imaging Biomarkers in Parkinsonian Syndromes") - [A deep-learning based framework for brain-atrophy measurement - AD/PD 2021](/news-and-resources/webinars/a-deep-learning-based-framework-for-brain-atrophy-measurement/ "A deep-learning based framework for brain-atrophy measurement - AD/PD 2021") - [Using AI To Advance Imaging Operations & Analysis in Phase III Clinical Trials for Alzheimer’s](/news-and-resources/webinars/advancing-imaging-operations-and-analysis-in-alzheimers-disease-late-stage-clinical-trialsg-post/ "Using AI To Advance Imaging Operations & Analysis in Phase III Clinical Trials for Alzheimer’s") - [MIUA 2020: Transfer Learning for Brain Segmentation: Pre-task Selection and Data Limitations](/news-and-resources/webinars/miua-2020/ "MIUA 2020: Transfer Learning for Brain Segmentation: Pre-task Selection and Data Limitations") - [Free Water Imaging in Alzheimer's Disease](/news-and-resources/webinars/free-water/ "Free Water Imaging in Alzheimer's Disease") - [ Using AI to optimize Tau PET Imaging for Alzheimer’s Disease Clinical Development](/news-and-resources/webinars/using-ai-to-optimize-tau-pet-imaging-for-alzheimers-disease-clinical-development/ " Using AI to optimize Tau PET Imaging for Alzheimer’s Disease Clinical Development") - [AD: Comorbidities, Novel Targets, and Imaging Through the Neuroradiologist’s Lens](/news-and-resources/webinars/alzheimers-landscapes-comorbidities-novel-targets-and-imaging-through-the-neuroradiologists-lens/ "Alzheimer’s Landscapes: Comorbidities, Novel Targets, and Imaging Through the Neuroradiologist’s Lens") - [ Advancing AD Clinical Trials Through Blood-Based Biomarkers & Amyloid PET Webinar](/news-and-resources/webinars/advancing-ad-clinical-trials-through-blood-based-biomarkers-and-amyloid-pet-webinar/ " Advancing AD Clinical Trials Through Blood-Based Biomarkers & Amyloid PET Webinar") - [Endpoint selection in Huntington’s disease trials: how neuroimaging advances drive better outcomes](/news-and-resources/webinars/endpoint-selection-in-huntingtons-disease-clinical-trials-and-how-advances-in-neuroimaging-can-drive-better-trial-outcomes/ "Endpoint selection in Huntington’s disease trials: how neuroimaging advances drive better outcomes") - [Understanding Imaging in Parkinson’s Disease Trials: From Eligibility to Efficacy](/news-and-resources/webinars/understanding-imaging-in-parkinsons-disease-trials-from-eligibility-to-efficacy/ "Understanding Imaging in Parkinson’s Disease Trials: From Eligibility to Efficacy") - [Where Vascular Disease and Alzheimer’s Meet: Shared Pathways to Cognitive Decline ](/news-and-resources/webinars/where-vascular-disease-and-alzheimers-meet-shared-pathways-to-cognitive-decline/ "Where Vascular Disease and Alzheimer’s Meet: Shared Pathways to Cognitive Decline ") - [Downloads](/news-and-resources/downloads/ "Downloads") - [Huntington's Disease: Your Imaging Analysis & Operations Solutions Partner ](/news-and-resources/downloads/huntingtons-disease-your-imaging-analysis-and-operations-solutions-partner/ "Huntington's Disease: Your Imaging Analysis & Operations Solutions Partner ") - [Your Imaging Analysis & Operations Experts in Alzheimer’s Disease Clinical Research](/news-and-resources/downloads/your-imaging-analysis-and-operations-experts-in-alzheimers-disease-clinical-research/ "Your Imaging Analysis & Operations Experts in Alzheimer’s Disease Clinical Research") - [Executing a Multi-Arm Phase 1 Alzheimer’s Disease Global Clinical Trial with Clinilabs and IXICO](/news-and-resources/downloads/executing-a-multi-arm-phase-1-alzheimers-disease-global-clinical-trial-with-clinilabs-and-ixico/ "Executing a Multi-Arm Phase 1 Alzheimer’s Disease Global Clinical Trial with Clinilabs and IXICO") - [Your Partner in Parkinson's Disease Imaging Analysis and Operations Solutions](/news-and-resources/downloads/parkinsons-disease-imaging-analysis-and-operations-solutions/ "Your Partner in Parkinson's Disease Imaging Analysis and Operations Solutions") - [Blog](/news-and-resources/blog/ "Blog") - [Why partnerships are the promising pathway for Alzheimer’s breakthroughs](/news-and-resources/blog/why-partnerships-are-the-promising-pathway-for-alzheimers-breakthroughs/ "Why partnerships are the promising pathway for Alzheimer’s breakthroughs") - [The New Research Developments Driving Precision Care in Parkinson’s Disease ](/news-and-resources/blog/the-new-research-developments-driving-precision-care-in-parkinsons-disease/ "The New Research Developments Driving Precision Care in Parkinson’s Disease ") - [Imaging of Neurodegeneration within the NIA-AA Research Framework: The ‘N’ in the AT(N) Scheme](/news-and-resources/blog/imaging-of-neurodegeneration-within-the-nia-aa-research-framework-the-n-in-the-atn-scheme/ "Imaging of Neurodegeneration within the NIA-AA Research Framework: The ‘N’ in the AT(N) Scheme") - [Biomarkers and imaging in Alzheimer’s disease](/news-and-resources/blog/biomarkers-and-imaging-in-alzheimers-disease-understanding-amyloid-and-tau-within-the-atn-framework/ "Biomarkers and imaging in Alzheimer’s disease: Understanding Amyloid and Tau within the ATN Framework") - [A Quick Guide to Imaging Analysis & Operations Essentials in Alzheimer’s Disease Clinical Research](/news-and-resources/blog/a-quick-guide-to-imaging-analysis-and-operations-essentials-in-alzheimers-disease-clinical-research/ "A Quick Guide to Imaging Analysis & Operations Essentials in Alzheimer’s Disease Clinical Research") - [Innovation Trends in AD Research](/news-and-resources/blog/innovation-trends-in-ad-research-may-2025/ "Innovation Trends in AD Research –the shift to increasingly individualised trial design, therapeutics and care.") - [Imaging - Advancing Biomarker Research for Alzheimer’s Disease Diagnosis ](/news-and-resources/blog/imagingadvancing-biomarker-research-for-alzheimers-disease-diagnosis/ "Imaging - Advancing Biomarker Research for Alzheimer’s Disease Diagnosis ") - [Discussing research multi-biomarker advances in Alzheimer’s Disease at ADPD 2025](/news-and-resources/blog/discussing-research-multi-biomarker-advances-in-alzheimers-disease-at-adpd-2025/ "Discussing research multi-biomarker advances in Alzheimer’s Disease at ADPD 2025") - [International Women's Day 2025](/news-and-resources/blog/international-womens-day-2025/ "International Women's Day 2025") - [Alzheimer's Disease: The Role of Cutting-Edge Neuroimaging Techniques](/news-and-resources/blog/alzheimers-disease-the-role-of-cutting-edge-neuroimaging-techniques/ "Alzheimer's Disease: The Role of Cutting-Edge Neuroimaging Techniques") - [How Data, Imaging & AI Are Transforming MS Clinical Research](/news-and-resources/blog/how-data-imaging-and-ai-are-transforming-ms-clinical-research/ "How Data, Imaging & AI Are Transforming MS Clinical Research") - [CHDI's 17th Annual Therapeutics Conference: The Future of Huntington's Research](/news-and-resources/blog/chdis-17th-annual-therapeutics-conference-the-future-of-huntingtons-research/ "CHDI's 17th Annual Therapeutics Conference: The Future of Huntington's Research") - [GAP-Net Site Optimization Conference 2022: Event Review](/news-and-resources/blog/gap-net-site-optimization-conference-2022-event-review/ "GAP-Net Site Optimization Conference 2022: Event Review") - [IXICO & GAP Foundation: Alzheimer’s & The Bio-Hermes Study](/news-and-resources/blog/ixico-and-gap-foundation-alzheimers-and-the-bio-hermes-study/ "IXICO & GAP Foundation: Alzheimer’s & The Bio-Hermes Study") - [Discover IXIQ.Ai \| IXICO's AI-Based Brain Segmentation Platform](/news-and-resources/blog/discover-ixiq-ai-ixicos-ai-based-brain-segmentation-platform/ "Discover IXIQ.Ai | IXICO's AI-Based Brain Segmentation Platform") - [Interview with IXICO & GAP Foundation ](/news-and-resources/blog/interview-with-ixico-and-gap-foundation/ "Interview with IXICO & GAP Foundation ") - [Advancing Clinical And Imaging Biomarkers In Parkinson’s Disease Research](/news-and-resources/blog/advancing-clinical-and-imaging-biomarkers-in-parkinsons-disease-research/ "Advancing Clinical And Imaging Biomarkers In Parkinson’s Disease Research") - [Overcoming Imaging Challenges To Advance Huntington’s Disease Research](/news-and-resources/blog/overcoming-imaging-challenges-to-advance-huntingtons-disease-research/ "Overcoming Imaging Challenges To Advance Huntington’s Disease Research") - [Revolutionizing Analytics: The Role of Deep-Learning AI in CNS Clinical Trials](/news-and-resources/blog/revolutionizing-analytics-the-role-of-deep-learning-ai-in-cns-clinical-trials/ "Revolutionizing Analytics: The Role of Deep-Learning AI in CNS Clinical Trials") - [AAIC 2020 Day 3 Summary ](/news-and-resources/blog/aaic-2020-day-3-summary/ "AAIC 2020 Day 3 Summary ") - [AAIC 2020 Day Two Summary](/news-and-resources/blog/aaic-2020-day-one-summary-2/ "AAIC 2020 Day Two Summary") - [AAIC 2020 Day One Summary](/news-and-resources/blog/aaic-2020-day-one-summary/ "AAIC 2020 Day One Summary") - [The rise of digital health in the times of COVID-19](/news-and-resources/blog/digital-health-covid-19/ "The rise of digital health in the times of COVID-19") - [A Quick Guide to Imaging Analysis & Operations Essentials in Parkinson’s Disease Clinical Research](/news-and-resources/blog/a-quick-guide-to-imaging-analysis-and-operations-essentials-in-parkinsons-disease-clinical-research/ "A Quick Guide to Imaging Analysis & Operations Essentials in Parkinson’s Disease Clinical Research") - [Advancing AD Trials: Integrating Plasma Biomarkers and Imaging for Precision Enrolment](/news-and-resources/blog/advancing-ad-trials-integrating-plasma-biomarkers-and-imaging-for-precision-enrolment/ "Advancing AD Trials: Integrating Plasma Biomarkers and Imaging for Precision Enrolment") - [Exploring how GLP-1 Drugs and vascular biomarkers are shaping AD clinical trial design](/news-and-resources/blog/exploring-how-glp-1-drugs-and-vascular-biomarkers-are-shaping-alzheimers-disease-clinical-trial-design/ "Exploring how GLP-1 Drugs and vascular biomarkers are shaping Alzheimer’s Disease clinical trial design") - [The Emergence of Neuromelanin-Sensitive Imaging in Parkinson’s Disease Clinical Trials](/news-and-resources/blog/the-emergence-of-neuromelanin-sensitive-imaging-in-parkinsons-clinical-trials/ "The Emergence of Neuromelanin-Sensitive Imaging in Parkinson’s Disease Clinical Trials") - [Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics](/news-and-resources/blog/advancing-amyloid-assessment-in-pet-imaging-integrating-ai-with-quantitative-metrics/ "Advancing Amyloid Assessment in PET Imaging: Integrating AI with Quantitative Metrics") - [Multi-biomarker assessment to better understand clinical dementia symptoms](/news-and-resources/blog/multi-biomarker-assessment-to-better-understand-clinical-dementia-symptoms/ "Multi-biomarker assessment to better understand clinical dementia symptoms") - [Advancing a Multimodal Future for Alzheimer’s Disease Diagnosis](/news-and-resources/blog/advancing-a-multimodal-future-for-alzheimers-disease-diagnosis/ "Advancing a Multimodal Future for Alzheimer’s Disease Diagnosis") - [Advancing HD Clinical Trials with Automated Imaging: What the Latest Research Shows](/news-and-resources/blog/advancing-hd-clinical-trials-with-automated-imaging-what-the-latest-research-shows/ "Advancing HD Clinical Trials with Automated Imaging: What the Latest Research Shows") - [From Information to Intelligence: New Platform Identity Explained](/news-and-resources/blog/from-information-to-intelligence-bram-goodren-ceo-of-ixico-explains-the-new-identity-of-the-ixi-platform-and-why-it-matters/ "From Information to Intelligence: New Platform Identity Explained") - [Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/ "Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease") - [White Matter Hyperintensities: A precision neurology tool](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/ "White matter hyperintensities: A precision neurology tool for Alzheimer’s patient stratification and improved trial sensitivity? ") - [Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/ "Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials") - [Investors](/investors/ "Investor Relations | IXICO - AIM-Listed Neuroscience Company") - [Share Price](/investors/share-price/ "IXICO Share Price | Live Investor Information") - [Governance](/investors/#governance "Governance") - [AIM Rule 26 ](/investors/governance/aim-rule-26/ "AIM Rule 26 Disclosures | IXICO ") - [Our Board](/investors/governance/our-board/ "Our Board") - [Oversight](/investors/governance/oversight/ "Corporate Governance & Oversight | IXICO ") - [Contacts & Advisers ](/investors/governance/contacts-and-advisers/ "Contacts & Advisers | IXICO Investor Relations") - [Investor Resources](/investors/#investor-resources "Investor Resources") - [Company Documents](/investors/investor-resources/company-documents/ "Company Documents | IXICO Investor Resources") - [Financial Calendar](/investors/investor-resources/financial-calendar/ "Financial Calendar | IXICO Key Investor Dates") - [Investor Presentations](/investors/investor-resources/investor-presentations/ "Investor Presentations | IXICO ") - [Investor Videos](/investors/investor-resources/investor-videos/ "Investor Videos | IXICO Management Presentations") - [RNS News](/investors/investor-resources/rns-news/ "RNS News") - [Regulatory Email Alert](/investors/investor-resources/share-price-email-alert/ "Regulatory News Alert | IXICO Investor Updates") - [Shareholder Info ](/investors/investor-resources/shareholder-info/ "Shareholder Information | IXICO ") - [Recent Scientific Publications](/therapeutic-areas/recent-scientific-publications/ "Recent Scientific Publications") - [Contact Us](/contact-us/ "Contact IXICO | Get in Touch with Our Neuroimaging Experts") - [Submit RFP](/contact-us/submit-rfp/ "Submit RFP") - [Contact Us](/contact-us/ "Contact Us") - [Global Site Support](/contact-us/global-site-support/ "Global Site Support | Clinical Trial Imaging Assistance | IXICO") - [Terms and conditions](/terms-and-conditions/ "Terms & Conditions | IXICO ") - [Privacy Policy ](/privacy-policy/ "Privacy Policy | IXICO ") - [Website Privacy Policy ](/privacy-policy/website/ "Website Privacy Policy | IXICO") - [Business Partner and Supplier Privacy Notice](/privacy-policy/business-partner-and-supplier-privacy-notice/ "Business Partner & Supplier Privacy Notice | IXICO ") - [Site Management Privacy Policy and Terms of Use](/privacy-policy/site-management-and-terms-of-use/ "Site Management & Terms of Use | IXICO ") - [Shareholder Privacy Notice ](/privacy-policy/shareholder-privacy-notice/ "Shareholder Privacy Notice | IXICO") - [Cookie Policy](/cookie-policy/ "Cookie Policy") - [Sitemap](/sitemap/ "Sitemap")